site logo

ECRI CEO calls on FDA, industry to revisit COVID-19 medical device EUAs as shortages ebb

Marcus Schabacker contends the device approval system was already flawed before the pandemic, while noting concerns about cyberattacks and the jump in at-home care.

Permission granted by ECRI